Bacteremia in Children Hospitalized with Respiratory Syncytial Virus Infection

Miriam Cebey-López1,2, Jacobo Pardo-Seco1,2,3, Alberto Gómez-Carballa1,2,3

  • 1Grupo de Investigación en Genética, Vacunas, Infecciones y Pediatría (GENVIP - www.genvip.org), Hospital Clínico Universitario and Universidade de Santiago de Compostela (USC), Galicia, Spain.

Plos One
|February 13, 2016
PubMed

Insights

Bacteremia is uncommon in infants hospitalized with RSV respiratory infections. However, it is more prevalent in severe cases requiring intensive care and respiratory support.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • The incidence of bacteremia in children with acute bronchiolitis is generally considered low.
  • The precise rate of occult bacteremia in infants diagnosed with respiratory syncytial virus (RSV) infection remains unclear.
  • This study aimed to establish the prevalence and identify predictive factors for bacteremia in hospitalized children with confirmed RSV acute respiratory illness (ARI).

Purpose of the Study:

  • To determine the actual rate of bacteremia in infants hospitalized with RSV-associated acute respiratory illness (ARI).
  • To identify potential predictive factors associated with bacteremia in this pediatric population.
  • To compare the incidence of bacteremia using both conventional blood cultures and advanced molecular diagnostic techniques.

Main Methods:

  • A prospective, multicenter study was conducted between 2011 and 2013, enrolling children under two years old admitted for ARI.
  • Blood samples from RSV-positive patients were analyzed for bacterial presence using polymerase chain reaction (PCR) for common pathogens, alongside traditional culture methods.
  • Specific bacteria targeted by PCR included: *Neisseria meningitidis*, *Streptococcus pneumoniae*, *Haemophilus influenzae*, *Streptococcus pyogenes*, *Klebsiella pneumoniae*, *Pseudomonas aeruginosa*, *Escherichia coli*, and *Staphylococcus aureus*.

Main Results:

  • Out of 66 children with RSV-positive ARI, bacterial presence was detected in 10.6% (7 children).
  • The identified bacteria were *Haemophilus influenzae* (n=4) and *Streptococcus pneumoniae* (n=2).
  • Children with detected bacteremia showed significantly higher severity scores, including PICU admission (100% vs. 50%), need for respiratory support (100% vs. 18.6%), and longer hospitalization (12.1 vs. 7.5 days).

Conclusions:

  • Bacteremia is infrequent in infants hospitalized for RSV respiratory infections.
  • However, the possibility of bacteremia should be seriously considered in infants presenting with severe RSV illness.
  • The findings highlight the importance of considering bacterial coinfection in severe pediatric respiratory infections.
Abstract

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
12
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
36
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
33
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K